RT Journal Article
SR Electronic
T1 Evaluating the utility of high-resolution proximity metrics in predicting the spread of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.07.21258492
DO 10.1101/2021.06.07.21258492
A1 Zakaria Mehrab
A1 Aniruddha Adiga
A1 Madhav V. Marathe
A1 Srinivasan Venkatramanan
A1 Samarth Swarup
YR 2021
UL http://medrxiv.org/content/early/2021/06/10/2021.06.07.21258492.abstract
AB High resolution mobility datasets have become increasingly available in the past few years and have enabled detailed models for infectious disease spread including those for COVID-19. However, there are open questions on how such a mobility data can be used effectively within epidemic models and for which tasks they are best suited. In this paper, we extract a number of graph-based proximity metrics from high resolution cellphone trace data from X-Mode and use it to study COVID-19 epidemic spread in 50 land grant university counties in the US. We present an approach to estimate the effect of mobility on cases by fitting an ODE based model and performing multivariate linear regression to explain the estimated time varying transmissibility. We find that, while mobility plays a significant role, the contribution is heterogeneous across the counties, as exemplified by a subsequent correlation analysis. We subsequently evaluate the metrics’ utility for case surge prediction defined as a supervised classification problem, and show that the learnt model can predict surges with 95% accuracy and 87% F1-score.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by National Institutes of Health (NIH) Grant R01GM109718, NSF BIG DATA Grant IIS-1633028, NSF Grant No OAC-1916805, NSF Expeditions in Computing Grant CCF-1918656, CCF-1917819, NSF RAPID CNS-2028004, NSF RAPID OAC-2027541, US Centers for Disease Control and Prevention 75D30119C05935, DTRA subcontract-ARA S-D00189-15-TO-01-UVA, a grant from Google and VDH contract VDH-21-501-0141. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study at University of Virginia was approved by the Institutional Review Board for Social and Behavioral Sciences as part of the Human Research Protection Program.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregate proximity metric statistics used in this paper are available from the authors upon request.